Jolt Capital has made a strategic €24 million investment in BioSerenity, aiming to enhance the company's capabilities in the growing health technology sector in Europe.
Target Information
Jolt Capital is a prominent investment firm with a focus on technology growth sectors, especially in Europe. The firm has recently made significant investments in various tech-focused initiatives, aiming to accelerate development in emerging markets.
One of its latest targets includes a major funding round for BioSerenity, a company innovating in the health technology space. With an investment totaling €24 million, Jolt Capital supports BioSerenity's efforts to enhance medical data analysis and patient care.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The health technology industry in Europe is undergoing a transformative period, driven by advancements in data analytics, artificial intelligence, and telemedicine. Th
Similar Deals
Fonds Patient Autonome, Bpifrance, UNIQA, UI Investissement → Fizimed
2025
Jolt Capital
invested in
BioSerenity
in 2023
in a Other VC deal